[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: COVID-19 Hyper-Immuneglobulin (Human) solution: Manufacturer- Intas Pharmaceuticals Limited;Dosage Level(s)- 30 mL as an intravenous injection on day 1 & 2 at the rate of not more than 0.5mL/kg/h;Route of Administration- Intravenous injectionControl Intervention1: Standard of care: Standard of care is the treatment algorithm/modalities to be given at discretion of the investigator as defined in the latest Guidelines on Clinical Management of COVID-19 issued by Ministry of Health and Family Welfare; Government of India", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: COVID-19 Hyper-Immuneglobulin (Human) solution: Manufacturer- Intas Pharmaceuticals Limited;Dosage Level(s)- 30 mL as an intravenous injection on day 1 & 2 at the rate of not more than 0.5mL/kg/h;Route of Administration- Intravenous injection", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of care: Standard of care is the treatment algorithm/modalities to be given at discretion of the investigator as defined in the latest Guidelines on Clinical Management of COVID-19 issued by Ministry of Health and Family Welfare; Government of India", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 338, "treatment_name": "Covid19 hyper-immunoglobulin", "treatment_type": "Immunoglobulins sars-cov-2 specific", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: COVID-19 Hyper-Immuneglobulin (Human) solution: Manufacturer- Intas Pharmaceuticals Limited;Dosage Level(s)- 30 mL as an intravenous injection on day 1 & 2 at the rate of not more than 0.5mL/kg/h;Route of Administration- Intravenous injectionControl Intervention1: Standard of care: Standard of care is the treatment algorithm/modalities to be given at discretion of the investigator as defined in the latest Guidelines on Clinical Management of COVID-19 issued by Ministry of Health and Family Welfare; Government of India", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: COVID-19 Hyper-Immuneglobulin (Human) solution: Manufacturer- Intas Pharmaceuticals Limited;Dosage Level(s)- 30 mL as an intravenous injection on day 1 & 2 at the rate of not more than 0.5mL/kg/h;Route of Administration- Intravenous injection", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of care: Standard of care is the treatment algorithm/modalities to be given at discretion of the investigator as defined in the latest Guidelines on Clinical Management of COVID-19 issued by Ministry of Health and Family Welfare; Government of India", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]